The Epilepsy Foundation supports a series of grants and fellowships to advance the understanding of epilepsy that will lead to better treatment, more effective prevention, and ultimately to a cure. Funding is available to researchers at all professional levels including students, junior investigators and established investigators.
Please note that the Epilepsy Foundation Patent and Copyright Policy applies primarily to awards offered to academic institutions and is open to clarification as needed. Commercial companies that are offered funding to support their research will have the opportunity to negotiate a suitable agreement with the Foundation regarding intellectual property rights as needed.
The Epilepsy Foundation and the American Epilepsy Society announce changes to their Fellowship and Junior Investigator grant programs.
The Epilepsy Foundation and the American Epilepsy Society have each recently completed significant strategic planning efforts. Both organizations have affirmed their commitment to supporting early career researchers, and are announcing modifications to their respective funding programs reflecting their organizational focus.
For the 2015-2016 cycle, AES will provide funding for pre- and post-doctoral basic and clinical fellowships and Junior Investigator grants and EF will provide funding for clinical fellowship and new investigator awards under the following schedule:
November 6, 2015 Letters of Intent due
December 4-7, 2015 Opportunitiy for applicants to meet with mentors at AES meeting to discuss submissions
February 15, 2016 Applications due
April 1, 2016 Awards announced
The change in submission deadlines has been made in response to feedback from grant recipients and applicants to better align with the timing of fellowship appointments. In addition, this schedule will facilitate mentorship and applicant support resources through the AES Annual Meeting and other mechanisms.
To apply for the Pre-doctoral Research Training Fellowships, Post-doctoral Research Training Fellowships, Research Training Fellowship for Clinicians, the Junior Investigator Research Grant, and other AES funding opportunities go to https://www.aesnet.org/research/funding_for_junior_investigators
The following opportunities are now available for Fall 2015
- Epilepsy Foundation - New Therapy Commercialization Grants Program
- Epilepsy Innovation Seal of Excellence Award
- Targeted Research Initiative for Research Regarding Cannabidiol and Epilepsy
For researchers intending to apply for funding, please download the information and instructions for each program listed below.
LOI deadline: August 14, 2015, 11:59 PM ET
The Epilepsy Foundation - New Therapy Commercialization Grants Program supports the development of more effective therapies by serving as a catalyst for moving innovative therapies from the laboratory to the patient. Investigators must hold a relevant advanced degree (M.D., and/or Ph.D.), and have completed all research training. This call for proposals is open to investigators at corporations as well as the academic/university arena.
LOI deadline: August 14, 2015, 11:59 PM ET
The Epilepsy Innovation Seal of Excellence award is similar to the Epilepsy Foundation - New Therapy Commercialization Grants (NTCG) Program above, designed to accelerate the advancement of research from the laboratory to the patient. SEALs are provided to academic and commercial groups worldwide. The program seeks to advance the development of new therapies including but not limited to medicines, biologics or devices. All proposals must demonstrate a clear path from the lab to the patient and are evaluated with consideration for their potential value to patients, likelihood of successful development including regulatory approval and the timeframe of development. Drug development may be stimulated at the early phases leading to an IND.
The Epilepsy Innovation Seal of Excellence award is not primarily a grant program. The program provides a competitive, in-depth review by the Scientific and Business Advisory Boards, an actual SEAL that may be used by the awardee to generate interest in the project, and a one-time $25,000 grant for the research. The SEAL is awarded for one year, renewable upon application, for up to a total of four years; the funding for this award is only provided for the first year. The applicants will typically have a research budget of between 1 and $5M for the overall project--amounts that currently exceed the resources of the Epilepsy Foundation. The Epilepsy Foundation will assist the awardees in finding funds for the selected projects.
- Application Deadline: September 14, 2015
- Award Amount: up to $50,000 maximum for one year
- Apply via Proposal Central website
- Proposal Central website tip: filter the list to show Epilepsy Foundation programs
The Targeted Research Initiative for Research Regarding Cannabidiol and Epilepsy recognizes the increasing need for research regarding Cannabidiol. The purpose is to generate pilot data that can lead to sponsored research projects in the future. The Foundation invites research grant applications from interested investigators to conduct pilot research in the following areas. Projects should address at least one of the following numbered items and priority will be given to those that address at least one of the bulleted topics. 1. Fundamental knowledge of mechanism of action of Cannabidiol; 2. Fundamental knowledge of the consistency of products; 3. Cannabidiol therapeutics: *special interactions among AEDs and Cannabidiol, and *interactions of AEDs with epilepsy-associated, interictal dysfunctions of mood, anxiety and thought in those; and 4. Data base study.